Albert Bourla, Pfizer CEO (Evan Vucci, AP Images)

Covid-19 roundup: Pfiz­er tees up 500M vac­cine dos­es for do­na­tion in ex­pand­ed US pact; Ear­ly remde­sivir helps stave off hos­pi­tal­iza­tions — study

Pfiz­er and BioN­Tech will sell 500 mil­lion dos­es of their Comir­naty Covid-19 vac­cine to the US at cost as part of an ex­pand­ed agree­ment to dri­ve do­na­tions to low- and mid­dle-in­come na­tions, the drug­mak­er said Wednes­day.

The ex­pand­ed pact dou­bles Pfiz­er/BioN­Tech’s com­mit­ment to the US ef­fort, which will ship do­na­tions to CO­V­AX, a glob­al clear­ing­house for up to 92 tar­get na­tions, as well as the 55 mem­ber states of the African Union, Pfiz­er said. De­liv­er­ies start­ed in Au­gust and are ex­pect­ed to run through Sep­tem­ber 2022.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.